LONDON, May 7 (Reuters) - GlaxoSmithKline's newchairman Philip Hampton expressed support for the company'scurrent structure and its chief executive on Thursday whilespeaking to reporters after the drugmaker's annual meeting.
Hampton said he hopes CEO Andrew Witty will continue to runGSK for a good length of time, despite pressure from someshareholders for a change.
(Reporting by Ben Hirschler; Writing by Martinne Geller;Editing by David Goodman)